[{"Assets_0_Q2_USD":110797000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":2258000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":2252000000.0,"StockholdersEquityConverted_0_Q2_USD":36874000000.0,"StockholdersEquity_0_Q2_USD":36808000000.0,"RevenuesConverted_1_Q2_USD":11703000000.0,"RevenuesConverted_2_Q2_USD":22776000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":2227000000.0,"NetIncomeLossConverted_1_Q2_USD":1055000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":6884000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.36,"EarningsPerShareDiluted_1_Q2_USD":0.47,"EarningsPerShareBasic_2_Q2_USD":1.38,"EarningsPerShareBasic_1_Q2_USD":0.47,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.49,"NetIncomeLossConverted_2_Q2_USD":3076000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":2232000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210728"}]